BE762399A - Agent recalcifiant, procede de preparation et methode de recalcification - Google Patents

Agent recalcifiant, procede de preparation et methode de recalcification

Info

Publication number
BE762399A
BE762399A BE762399A BE762399A BE762399A BE 762399 A BE762399 A BE 762399A BE 762399 A BE762399 A BE 762399A BE 762399 A BE762399 A BE 762399A BE 762399 A BE762399 A BE 762399A
Authority
BE
Belgium
Prior art keywords
recalcifying
recalcification
agent
preparation process
preparation
Prior art date
Application number
BE762399A
Other languages
English (en)
Original Assignee
J Berthier S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Berthier S A Lab filed Critical J Berthier S A Lab
Publication of BE762399A publication Critical patent/BE762399A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126—Acids containing more than four carbon atoms
    • C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
BE762399A 1970-02-24 1971-02-02 Agent recalcifiant, procede de preparation et methode de recalcification BE762399A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR707006583A FR2077918B1 (fr) 1970-02-24 1970-02-24

Publications (1)

Publication Number Publication Date
BE762399A true BE762399A (fr) 1971-08-02

Family

ID=9051186

Family Applications (1)

Application Number Title Priority Date Filing Date
BE762399A BE762399A (fr) 1970-02-24 1971-02-02 Agent recalcifiant, procede de preparation et methode de recalcification

Country Status (7)

Country Link
US (1) US3814812A (fr)
BE (1) BE762399A (fr)
DE (1) DE2105925C3 (fr)
ES (1) ES388527A1 (fr)
FR (1) FR2077918B1 (fr)
GB (1) GB1301973A (fr)
NL (1) NL7102255A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017613A (en) * 1983-07-20 1991-05-21 Sanofi, S. A. Valproic acid preparations

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301176A (en) * 1980-08-18 1981-11-17 Warner-Lambert Company Method of administering calcium valproate
FR2547499A1 (fr) * 1983-06-15 1984-12-21 Opochimiotherapie Lab Medicaments contenant du dipropylacetate de calcium
US4913906B1 (en) * 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
US5070710A (en) * 1989-02-07 1991-12-10 Sara Lee Corporation Garment blank and method of making it
WO2007025177A2 (fr) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenese par modulation du recepteur muscarinique
EP2258358A3 (fr) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenèse avec un inhibiteur de l'acetylcholinestérase
EP2377530A3 (fr) 2005-10-21 2012-06-20 Braincells, Inc. Modulation de neurogénèse par inhibition PDE
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (fr) 2006-05-09 2011-10-19 Braincells, Inc. Neurogénèse par modulation de l'angiotensine
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080188457A1 (en) * 2007-02-02 2008-08-07 Braincells, Inc. Modulation of Neurogenesis with Biguanides and GSK3-beta Agents
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2266992A (en) * 1939-03-15 1941-12-23 American Cyanamid Co Therapeutic composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017613A (en) * 1983-07-20 1991-05-21 Sanofi, S. A. Valproic acid preparations

Also Published As

Publication number Publication date
DE2105925A1 (fr) 1971-09-09
DE2105925B2 (de) 1974-04-04
GB1301973A (fr) 1973-01-04
US3814812A (en) 1974-06-04
FR2077918A1 (fr) 1971-11-05
NL7102255A (fr) 1971-08-26
ES388527A1 (es) 1974-04-16
FR2077918B1 (fr) 1973-04-06
DE2105925C3 (de) 1974-11-21

Similar Documents

Publication Publication Date Title
BE762438A (fr) Procede de denicotinisation
BE799542A (fr) Cholesterol-oxydase et son procede de preparation,
BE762399A (fr) Agent recalcifiant, procede de preparation et methode de recalcification
CH550235A (fr) Procede de preparation de nouvelles diphenylamines.
BE746548A (fr) Nouvel oestratriol et procede de preparation
BE768119A (fr) Procede de preparation de cycloalcanols et de cycloalcanones
BE765287A (fr) Procede de preparation de derives de 3-
BE801604Q (fr) Procede de preparation de la dl-methionine
BE767935A (fr) Procede de forage dirige
BE777266A (fr) Procede de micro-encapsulation
BE763011A (fr) Procede de preparation de poly-organo-siloxanes
BE767990A (fr) Procede de preparation de monochlorobenzaldehydes
BE774905A (fr) Procede de preparation de metacroleine
BE762442A (fr) Procede de noircissement
BE774498A (fr) Procede de preparation de monofluoro-dichloromethane et de difluoro-monochloromethane
BE775519A (fr) Procede de preparation de saligenol
BE764472A (fr) Beta-rhodomycine v et son procede de preparation
BE801603Q (fr) Procede de preparation de la dl-methionine
BE777062A (fr) 3-sulfo-alkyl-6-hydroxy-pyridones-(2), leur procede de preparation et application
BE768303A (fr) Procede de preparation de 1,1,2,2-tetrahydroperfluoro- alcanols
BE764926A (fr) Procede de concentration
BE777447A (fr) Procede de preparation de monothioalkylene-glycols
BE761797A (fr) Procede de preparation de vinyl-trichlorosilane
BE768655A (fr) Procede de preparation de zearalenone
BE788558A (fr) Reglette de raccordement et son procede de